While the surgical excision of tumours is generally accepted to offer the best long-term solution, it is often not possible due to the size, number or location of the tumour. IO therapies may be applied to shrink the tumour, making a surgical or interventional treatment possible.
The annual ECIO meeting offers all physicians interested in image-guided oncological therapies an opportunity to learn about new developments and discuss best practice. Since the early days of image-guided biopsies and palliative stenting, the field has expanded to cover a staggering range of clinical options.
Next year’s meeting, to be held Dublin, Ireland, will endeavour to cover a broad cross-section of these therapies, focusing on the most recent advances:
Colorectal liver metastases
A core theme will be metastatic colorectal liver cancer. More than one million new colorectal patients are seen each year worldwide: approximately 15% of these have liver metastases at diagnosis and around 60% develop these during follow-up. Recent interventional oncology data demonstrate some promising adjuvant therapies, as well as increased survival time and improved quality of life in unresectable patients. These treatments and their clinical application will be thoroughly examined in number of Clinical Focus Sessions and a Multidisciplinary Tumour Board.
A varied programme
Other topics to be discussed include staples such as imaging, HCC, lung cancers, new developments and the clinical management of patients. The 2016 meeting will also feature a dedicated immunotherapy session – an exciting field which deserves the attention of the oncology community. The conference will also address newer clinical territories such as neuroendocrine tumours and cholangiocarcinoma, as well as hosting a discussion on quality assurance in the IO field.